FDA Issues Draft Guidance on Pregnant Women in Clinical Trials

Share this post

The draft guidance for industry outlines the scientific and ethical issues to address when considering the inclusion of pregnant women in clinical trials of drugs and biological products.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply